STOCK TITAN

Trxade Health Inc - MEDS STOCK NEWS

Welcome to our dedicated news page for Trxade Health (Ticker: MEDS), a resource for investors and traders seeking the latest updates and insights on Trxade Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Trxade Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Trxade Health's position in the market.

Rhea-AI Summary
TRxADE HEALTH Inc. (MEDS) declares a special cash dividend of $8.00 per share of common stock, funded by the sale of web-based market platform assets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
107.21%
Tags
dividends
-
News
Rhea-AI Summary
TRxADE HEALTH, INC. (NASDAQ: MEDS) filed its Quarterly Report on Form 10-Q for the period ended September 30, 2023, regaining compliance with Nasdaq Listing Rule 5250(c)(1) after receiving a notice of noncompliance. The parent company of a pharmaceutical business-to-business exchange platform, TRxADE, believes it has addressed the issue.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.06%
Tags
none
-
Rhea-AI Summary
TRxADE HEALTH, INC. (NASDAQ: MEDS) received a notice of non-compliance from Nasdaq due to the failure to timely file its Quarterly Report on Form 10-Q. The company has 60 days to submit a plan to regain compliance and can be granted up to 180 days to do so. TRxADE is working to complete the Form 10-Q and intends to file it as soon as possible.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.54%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.88%
Tags
none
-
Rhea-AI Summary
Superlatus subsidiary enters distribution agreement with Rainforest Distribution Corp.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.12%
Tags
partnership
-
Rhea-AI Summary
Superlatus, Inc. acquires Spero Foods, a plant-based tech company specializing in alternative dairy and egg replacements. The acquisition expands Superlatus' portfolio of CPG brands. Spero has 21 global patents and patents pending, and plans major innovations for 2024. Spero aims to build a world-leading plant-based company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.06%
Tags
acquisition
Rhea-AI Summary
TRxADE Health, Inc. (NASDAQ:MEDS) merges with Superlatus, Inc. and acquires The Urgent Company Inc. to enhance its position in sustainable food products and enter new markets. Superlatus plans to introduce pulse-based twisted protein snacks through Brave Robot brand. Snacks have 25% fewer calories, over 300% more protein, 200% more fiber, 40% less fat, 67% less saturated fat, and 20% less sodium for less than $2.00 per bag. The acquisition will expand consumer brands' presence in retail stores.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.9%
Tags
acquisition
-
Rhea-AI Summary
Superlatus Inc. merges with TRxADE HEALTH and plans to revolutionize the snack industry with pulse-based twisted protein snacks under the Brave Robot brand. The snacks aim to solve the problem of empty calories and offer healthier options with lower calories, more protein and fiber, and less fat and sodium. The snacks are already being sold in Canada and will be introduced in the US in early 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
TRxADE HEALTH, Inc. (NASDAQ: MEDS) to acquire The Urgent Company and its consumer brands from Perfect Day, strengthening Superlatus' leadership in sustainable food production and expanding market share. Acquisition expected to accelerate transition to animal-free products and increase retail footprint.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.74%
Tags
acquisition
Rhea-AI Summary
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Files for Extension to Submit Q2 Quarterly Report, Citing Merger Transaction as Reason. Financial Results to be Released on August 18, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.8%
Tags
none
Trxade Health Inc

Nasdaq:MEDS

MEDS Rankings

MEDS Stock Data

12.34M
452.08k
28.08%
5.66%
4.65%
Wholesale Trade Agents and Brokers
Wholesale Trade
Link
US
Lutz

About MEDS

trxade.com is quickly becoming the nation's largest web-based pharmaceutical purchasing and analytics system. our revolutionary supplier e-stores allow buyers to shop and compare products and pricing of pharmaceutical suppliers nationwide. this forward thinking platform creates supplier competition and drives down cost for the buyers like never before. our secure system also allows buyers to track all of their purchases in one, easy to manage location with analytical tools available to make more educated and informed purchasing decisions. trxade.com membership is offered only to licensed pharmaceutical buyers (pharmacies, long term care facilities, hospitals, physicians, etc.). our safe and secure system allows buyers to search for products, compare pricing and submit immediate purchase orders to some of the nation's most well known and respected suppliers.